CHAN HENG FAI AMBROSE sold 77.5% of their position (2.53M shares) of IMPACT BIOMEDICAL INC. on the open market
Open‑market sale worth $2.91M — a major position exit. Review remaining holdings and any 10b5‑1 plan disclosures.
S · 4 sales
Filed: 4/2/2025ACC: 0001641172-25-002479
10% Owner
Since Sep 2024
-2.53M
Net shares
Net seller
$2.91M
Total sold
4
Open market trades
0B · 4S
4
Total transactions
2.53M disposed
Non-Derivative Transactions4
Common Stock
Indirect
Shares
−300K
Price / share
$1.03
Trade value
$308.40K
% of position
19.3%
3/31/2025
1.55M→1.25M
Common stock
Indirect
Shares
−400K
Price / share
$0.98
Trade value
$392.80K
% of position
31.9%
4/1/2025
1.25M→853.90K
Common Stock
Indirect
Shares
−650K
Price / share
$1.45
Trade value
$940.55K
% of position
25.4%
4/1/2025
2.56M→1.91M
Common Stock
Indirect
Shares
−1.18M
Price / share
$1.08
Trade value
$1.27M
% of position
61.6%
4/1/2025
1.91M→734.06K
Total
Net shares
−2.53M
Net value
-$2.91M
| Security | Date | Type | Shares | Price / Share | Trade Value | % of Position | Held Before | Held After |
|---|---|---|---|---|---|---|---|---|
| Common Stock Indirect | 3/31/2025 | S · Sale | −300K | $1.03 | $308.40K | 19.3% | 1.55M | 1.25M |
| Common stock Indirect | 4/1/2025 | S · Sale | −400K | $0.98 | $392.80K | 31.9% | 1.25M | 853.90K |
| Common Stock Indirect | 4/1/2025 | S · Sale | −650K | $1.45 | $940.55K | 25.4% | 2.56M | 1.91M |
| Common Stock Indirect | 4/1/2025 | S · Sale | −1.18M | $1.08 | $1.27M | 61.6% | 1.91M | 734.06K |
| Total | −2.53M | -$2.91M | ||||||
Derivative Transactions0
No derivative transactions reported